Education
About Us
Working with TipRanks
Follow Us
Quanterix Corporation (QTRX)
NASDAQ:QTRX
QTRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.05 - $16.74
Previous CloseN/A
Volume125.22K
Average Volume (3M)783.51K
Market Cap
$258.38M
Enterprise Value$217.69M
Total Cash (Recent Filing)$266.88M
Total Debt (Recent Filing)$36.41M
Price to Earnings (P/E)―
Beta1.28
Next Earnings
Aug 11, 2025EPS Estimate
-0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.53
Shares Outstanding38,854,877
10 Day Avg. Volume910,640
30 Day Avg. Volume783,510
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)1.43
Price to Sales (P/S)0.00
P/FCF Ratio-8.54
Enterprise Value/Market Cap0.84
Enterprise Value/Revenue0.41
Enterprise Value/Gross Profit2.78
Enterprise Value/Ebitda-1.14
Forecast
1Y Price Target
$9.50Price Target Upside42.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Quanterix News
Bulls Say, Bears Say
Bulls Say
Cost Synergy ExpectationsQTRX now expects to realize $55M in cost synergies with AKYA to maintain 2026 cash flow profitability target, driven by facility consolidation and deduplication of G&A and sales support.
Insider ConfidenceRecent insider purchases could suggest these individuals believe the stock is undervalued.
Product Launch And Acquisition BenefitsNew product launches and benefits from the Akoya acquisition should drive stronger performance and valuation levels higher for QTRX over time.
Bears Say
Alzheimer's Diagnostics CompetitionThere are risks of QTRX falling behind in the Alzheimer's diagnostics market, with competitors already obtaining or planning FDA approvals.
Integration RisksThe acquisition adds integration risks to an already challenging macro backdrop and reduces cash flexibility for QTRX.
Macro HeadwindsMacro headwinds and continued NIH funding noise have led to relatively flat consumables and a significant sequential decrease in instrument revenue.
Ownership Overview
8.59% Insiders
18.18% Mutual Funds
39.42% Other Institutional Investors
22.48% Public Companies and Individual Investors
QTRX FAQ
What was Quanterix Corporation’s price range in the past 12 months?
Quanterix Corporation lowest stock price was $4.05 and its highest was $16.74 in the past 12 months.
What is Quanterix Corporation’s market cap?
Quanterix Corporation’s market cap is $258.38M.
When is Quanterix Corporation’s upcoming earnings report date?
Quanterix Corporation’s upcoming earnings report date is Aug 11, 2025 which is in 42 days.
How were Quanterix Corporation’s earnings last quarter?
Quanterix Corporation released its earnings results on May 12, 2025. The company reported -$0.53 earnings per share for the quarter, missing the consensus estimate of -$0.435 by -$0.095.
Is Quanterix Corporation overvalued?
According to Wall Street analysts Quanterix Corporation’s price is currently Undervalued.
Does Quanterix Corporation pay dividends?
Quanterix Corporation does not currently pay dividends.
What is Quanterix Corporation’s EPS estimate?
Quanterix Corporation’s EPS estimate is -0.4.
How many shares outstanding does Quanterix Corporation have?
Quanterix Corporation has 38,854,877 shares outstanding.
What happened to Quanterix Corporation’s price movement after its last earnings report?
Quanterix Corporation reported an EPS of -$0.53 in its last earnings report, missing expectations of -$0.435. Following the earnings report the stock price went down -19.023%.
Which hedge fund is a major shareholder of Quanterix Corporation?
Currently, no hedge funds are holding shares in QTRX
Quanterix Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.50 (42.86% Upside)
$9.50 (42.86% Upside)
Hedge Fund Trend
Decreased
By 53.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $2.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 3.7%
Last 30 Days ▲ 13.5%
Last 30 Days ▲ 13.5%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.84%
12-Months-Change
Fundamentals
Return on Equity
-14.51%
Trailing 12-Months
Asset Growth
-4.27%
Trailing 12-Months
Company Description
Quanterix Corporation
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
QTRX Company Deck
QTRX Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Quanterix demonstrated resilience in consumables and strategic advancements, such as new product launches and significant merger synergies, but faced challenges with declining total revenue, increased expenses, and macroeconomic pressures leading to a more conservative revenue outlook.Read More>QTRX Stock 12 Month Forecast
Average Price Target
$9.50
▲(42.86%Upside)